Cardiovascular Medicine

3 pages, 647 KB

Open AccessInteresting Images

Just a Supraventricular Tachycardia

by Christian Balmer and Matthias Gass

Cardiovasc. Med. 2011, 14(10), 294; https://doi.org/10.4414/cvm.2011.01619 - 26 Oct 2011

Viewed by 11

Abstract

Case report. A 16-year-old female was seen for recurrent episodes of supraventricular tachycardia [...] Full article

4 pages, 1208 KB

Open AccessCase Report

Transcoronary Alcohol Ablation—On Behalf of Three Cases with Hypertrophic Obstructive Cardiomyopathy

by Alexander Breitenstein, Jasmina Alibegovic, David Hürlimann, Patric Biaggi, Roberto Corti and Thomas F. Lüscher

Cardiovasc. Med. 2011, 14(10), 290; https://doi.org/10.4414/cvm.2011.01615 - 26 Oct 2011

Viewed by 13

Abstract

Hypertrophic cardiomyopathy (HCM) is a common genetic disorder with an estimated prevalence of 1:500. About a quarter of the patients with HCM have left ventricular outflow tract obstruction referred to as hypertrophic obstructive cardiomyopathy (HOCM). Even with optimal medical treatment using negative inotropic drugs such as β-blockers and first generation calcium-antagonists, about 5–10% of patients with HOCM remain refractory to therapy. In such cases, reduction of the outflow gradient by either surgical myectomy or catheter-based alcohol septal ablation represent further treatment options. Even though myectomy historically is considered the gold standard, interventional alcohol ablation of the septum has become the treatment of choice in many centres. We present the history of three patients suffering from HOCM, who were successfully treated by catheter-based alcohol septal ablation. Full article

4 pages, 804 KB

Open AccessCase Report

Left Main Stem Thrombosis in a 37-Year-Old Man

by Stéphane Noble, Caroline Frangos and Marco Roffi

Cardiovasc. Med. 2011, 14(10), 286; https://doi.org/10.4414/cvm.2011.01614 - 26 Oct 2011

Viewed by 14

Abstract

A 37-year-old man, with active smoking and dyslipidemia as cardiovascular risk factors, presented with acute anterior ST segment elevation myocardial infarction. Emergent coronary angiography demonstrated a left main coronary artery occlusion. Following primary percutaneous coronary intervention, the patient survived and was free of [...] Read more.

3 pages, 762 KB

Open AccessCase Report

A Case for Incidental Coronary Angiography During Percutaneous Closure of the Patent Foramen Ovale?

by Nikesh Raj Shrestha, Thomas Pilgrim, Alexander Kadner and Bernhard Meier

Cardiovasc. Med. 2011, 14(10), 283; https://doi.org/10.4414/cvm.2011.01616 - 26 Oct 2011

Viewed by 12

Abstract

A 42-year-old male had undergone a successful closure of a patent foramen ovale (PFO) seven years earlier for cryptogenic stroke. In spite of several risk factors an incidental coronary angiogram was not performed due to his young age (35 years at that time). Seven years later a myocardial infarction (MI) caused an apical ventricular septal defect (VSD) necessitating a surgical correction. Finally device closure became necessary due to patch dehiscence. Incidental coronary angiography on the occasion of PFO closure would have resulted i n timely coronary treatment by acetylsalicylic acid and a statin and perhaps coronary angioplasty. The MI and its complicated course could most likely have been prevented. Full article

6 pages, 546 KB

Open AccessEditorial

How to Transform You into a Radialist: Literature Review

by Caroline Frangos and Stéphane Noble

Cardiovasc. Med. 2011, 14(10), 277; https://doi.org/10.4414/cvm.2011.01618 - 26 Oct 2011

Cited by 9 | Viewed by 16

Abstract

Since the first transradial percutaneous coronary intervention in 1992 by Kiemenij, this technique has been performed heterogeneously around the world with increasing interest due to recent reports in the literature. I ndeed, this approach decreases access site complications and major bleeding and increases patient comfort. All patient subgroups benefit from this approach, especially in cases of acute coronary syndromes where the risk of bleeding is highest. In this review, we will address the debate between femoralists and radialists with regard to pre-RIVAL studies and including the RIVAL randomised trial. The aim of this literature review is to demonstrate that ignoring the transradial approach can no longer be justified. Full article

6 pages, 565 KB

Open AccessReview

Prevalence, Mechanism and Management of Atrial Fibrillation in Athletes

by Naiara Calvo and Lluís Mont

Cardiovasc. Med. 2011, 14(10), 271; https://doi.org/10.4414/cvm.2011.01617 - 26 Oct 2011

Viewed by 14

Abstract

Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice with an estimated prevalence of 0.4% to 1% in the general population [1], increasing with age to 8% in those older than 80 years [2]. The recognised risk factors for developing AF include age, structural heart disease, hypertension, diabetes mellitus and hyperthyroidism [3]. However, the mechanisms underlying the onset and maintenance of AF in patients younger than 60 years in whom no cardiovascular disease or any other known causal factor is present are yet to be clarified. This condition is termed lone AF [4], and may be responsible for as many as 30% of patients with paroxysmal AF seeking medical attention [5, 6]. It is well known that regular exercise is beneficial to health and reduces the risks of cardiovascular diseases [7, 8]. However, recent studies suggest that longterm endurance exercise may increase the incidence of AF [9–16]. This review article is intended to analyse the possible links between AF and endurance sport practice, the pathophysiological mechanisms responsible for this association and the recommended therapeutic options. Full article

Journal Menu

Journal Browser

Cardiovasc. Med., Volume 14, Issue 10 (10 2011) – 6 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI